TAYTULLA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jan 2024)
What this means for you
Registered since 24 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87271498
- Registration number
- 5315158
- Mark type
- Design + words
- Filed
- 16 Dec 2016
- Published for opposition
- 08 Aug 2017
- Registered
- 24 Oct 2017
- Attorney of record
- Janie L. Thompson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of bacterial infections, pain, cardiovascular system diseases and disorders, respiratory system diseases and disorders, central nervous system diseases and disorders; antidepressants; antipsychotics
Owner
- Allergan Pharmaceuticals International Limited, Coolock, Dublin 17, IE
- Allergan Pharmaceuticals International Limited, Coolock, Dublin 17, IE
- Allergan Pharmaceuticals International Limited, Coolock, Dublin 17, IE
Prosecution history
- 13 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 24 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2017 — PUBLISHED FOR OPPOSITION
- 19 Jul 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jun 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jun 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jun 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Mar 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Mar 2017 — NON-FINAL ACTION E-MAILED